Can Seroquel Cause Breast Discharge?
Yes, Seroquel (quetiapine) can cause breast discharge (galactorrhea) through drug-induced hyperprolactinemia, though this occurs less frequently than with other antipsychotics like risperidone or amisulpride. While quetiapine is generally considered "prolactin-sparing," galactorrhea has been documented even at low doses in susceptible individuals 1, 2, 3, 4.
Mechanism and Incidence
Quetiapine causes galactorrhea through dopamine D2 receptor antagonism, leading to elevated prolactin levels 1. The FDA label explicitly lists galactorrhea as a reported adverse reaction 1. Large-scale pharmacovigilance data from 320,383 patients found quetiapine had a "prominent role" in causing galactorrhea in at least 3 documented cases, though this was substantially less common than with risperidone (52 cases, 0.19% incidence) or amisulpride (30 cases, 0.48% incidence) 2.
Key clinical point: Galactorrhea with quetiapine appears dose-dependent 3 and can occur even at doses as low as 100 mg daily 4.
Evaluation Algorithm
When a patient on Seroquel presents with breast discharge:
1. Confirm the diagnosis
- Verify milky discharge (not bloody, serous, or purulent which suggests pathologic causes)
- Rule out physiologic lactation (within 1 year postpartum/breastfeeding cessation) 5
2. Obtain serum prolactin level 6
- Draw at any time of day; single determination usually sufficient 6
- Medication-induced hyperprolactinemia typically produces prolactin levels 25-100 ng/mL, though quetiapine can occasionally cause levels >200 ng/mL 6
- Critical caveat: If you see a very large pituitary mass with only mildly elevated prolactin, order serial dilutions to rule out "hook effect" artifact 6
3. Rule out other causes 6
- Pregnancy test (premenopausal women)
- TSH (hypothyroidism)
- Creatinine (renal insufficiency)
- Review all medications for other dopamine antagonists
4. If prolactin remains elevated and onset doesn't coincide with quetiapine initiation, obtain pituitary MRI 6
This differentiates medication-induced hyperprolactinemia from a pituitary/hypothalamic mass.
Management Strategy
For Symptomatic Patients:
First-line approach: Discontinue quetiapine for 3 days and remeasure prolactin 6. Prolactin levels typically normalize within 3 days after stopping the offending drug 6. Do not discontinue antipsychotics without consulting the prescribing psychiatrist 6.
If quetiapine cannot be discontinued:
Switch to an alternative antipsychotic with lower prolactin elevation risk 6:
- Aripiprazole (has dopamine agonist activity and can actually lower prolactin) 6
- Other atypical antipsychotics with lower D2 antagonism 6
- Case series show galactorrhea resolved and prolactin normalized after switching to quetiapine from other antipsychotics 7, suggesting quetiapine itself may be the alternative when switching FROM higher-risk agents
Cautious dopamine agonist therapy (controversial) 6:
For Asymptomatic Patients:
No treatment is necessary for asymptomatic medication-induced hyperprolactinemia 6.
Exception: If long-term hypogonadism develops (amenorrhea, low libido, erectile dysfunction, or low bone mass), consider estrogen or testosterone replacement rather than stopping the antipsychotic 6. Antipsychotic-induced hyperprolactinemia increases bone loss risk, particularly in women 6.
Important Clinical Pitfalls
- Don't assume quetiapine is completely "prolactin-neutral" – while less likely than risperidone or typical antipsychotics, galactorrhea can still occur 2, 3, 4
- Higher doses correlate with higher galactorrhea rates 2, 3 – consider dose reduction if clinically appropriate
- Screen for macroprolactinemia in asymptomatic patients with elevated prolactin using polyethylene glycol precipitation 6 – approximately 40% of hyperprolactinemia cases are macroprolactinemia, which is less bioactive and may not require intervention
- Young women (ages 16-30) have highest incidence of antipsychotic-induced galactorrhea 2